Inhalation Anesthetics
Description
Global Inhalation Anesthetics Market to Reach US$2.5 Billion by 2032
The global market for Inhalation Anesthetics estimated at US$1.6 Billion in the year 2025, is expected to reach US$2.5 Billion by 2032, growing at a CAGR of 6.8% over the analysis period 2025-2032. Sevoflurane Drug, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$988.6 Million by the end of the analysis period. Growth in the Desflurane Drug segment is estimated at 5.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$457.3 Million While China is Forecast to Grow at 6.5% CAGR
The Inhalation Anesthetics market in the U.S. is estimated at US$457.3 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$437.5 Million by the year 2032 trailing a CAGR of 6.5% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.
Global Inhalation Anesthetics Market - Key Trends & Drivers Summarized
What Are Inhalation Anesthetics, and What Role Do They Play in Modern Medicine?
Inhalation anesthetics are gases or volatile liquids that are administered to patients during surgical procedures to induce and maintain general anesthesia. These substances, which include agents such as isoflurane, sevoflurane, and desflurane, are preferred in many surgical settings due to their rapid onset and easy reversibility. Their ability to control the depth of anesthesia with adjustments in concentration and flow rates makes them indispensable in ensuring patient safety and comfort during operations. The administration of inhalation anesthetics is typically conducted through modern anesthesia machines that allow for precise control over dosage and mixture with oxygen, which is critical for patient safety.
How Are Advancements in Medical Practices Enhancing the Use of Inhalation Anesthetics?
Advancements in medical practices and surgical techniques have greatly influenced the development and use of inhalation anesthetics. The trend towards minimally invasive surgeries, which require shorter recovery times and reduce the risk of complications, has supported the demand for anesthetics that are easy to administer and adjust. Developments in monitoring technology have also improved the safety of using inhalation anesthetics, enabling anesthesiologists to maintain optimal sedation levels while monitoring vital signs to prevent adverse reactions. Furthermore, ongoing research into the pharmacological properties of inhalation anesthetics is leading to the formulation of newer agents that are less likely to cause side effects and are more environmentally friendly.
What Challenges Are Faced by the Inhalation Anesthetics Market?
The inhalation anesthetics market faces challenges related to the side effects and environmental impact of anesthetic gases. Some inhalation anesthetics are known to contribute to greenhouse gas emissions, which poses environmental and regulatory challenges. Additionally, concerns about the neurotoxicity of some anesthetics, particularly in vulnerable populations such as infants and the elderly, call for more research and careful management. However, these challenges drive the development of new anesthetic formulations and delivery systems that are safer for patients and less harmful to the environment. The adoption of closed-loop anesthesia systems, which reduce wastage and minimize exposure to healthcare workers, is one such innovation that addresses both safety and environmental concerns.
Growth in the Inhalation Anesthetics Market Is Driven by Several Factors…
The growth in the inhalation anesthetics market is driven by several factors, including the increasing number of surgical procedures globally, which directly correlates with the rising demand for effective anesthetic agents. Technological advancements in anesthesia delivery systems, which enhance the safety and efficacy of inhalation anesthetics, also contribute to market growth. Moreover, the expanding elderly population, which is more prone to chronic diseases requiring surgical interventions, supports the sustained demand for inhalation anesthetics. Economic factors, such as the growing healthcare expenditure in emerging economies and the development of healthcare infrastructure, further drive the market. Additionally, ongoing research into safer and more efficient anesthetic agents continues to open new avenues for market expansion. Collectively, these factors ensure a robust growth trajectory for the inhalation anesthetics market, reflecting its crucial role in facilitating safe surgical care.
The report analyzes the Inhalation Anesthetics market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Sevoflurane, Desflurane, Nitrous Oxide, Isoflurane); Application (Maintenance, Induction)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
SELECT PLAYERS -
- 058 LatchGas
- Abbott Laboratories, Inc.
- AbbVie, Inc.
- Accutron
- Baxter International, Inc.
- Chester County Family Dentistry
- Discover Dental
- Eisai Co., Ltd.
- Fox Family Dentistry
- Fresenius Kabi AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
- How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
- Inhalation Anesthetics – Global Key Competitors Percentage Market Share in 2026 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
- Global Economic Update
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Advancements in Anesthetic Delivery Systems Propel Development of Next-Generation Inhalation Anesthetics
- Rising Demand for Outpatient Surgeries Spurs Growth in Inhalation Anesthetics Market
- Increasing Adoption of Inhalation Anesthetics in Ambulatory Surgical Centers Expands Market Potential
- Growth in Geriatric Population Drives Demand for Safe and Effective Anesthesia Solutions
- Rising Focus on Patient Safety and Postoperative Outcomes Strengthens Business Case for Inhalation Anesthetics
- The Role of Inhalation Anesthetics in Enhancing Efficiency of Shorter Surgical Procedures Fuels Market Growth
- Growing Adoption of Inhalation Anesthetics in Pediatric Surgeries Expands Addressable Market
- Increasing Use of Inhalation Anesthetics in Veterinary Medicine Generates Demand in Non-Human Applications
- Rising Incidence of Chronic Diseases Requiring Surgical Interventions Propels Growth in Inhalation Anesthetics
- The Impact of Technological Innovations in Anesthesia Machines on the Inhalation Anesthetics Market
- Focus on Reducing Environmental Impact Drives Innovation in Eco-Friendly Inhalation Anesthetics
- Growing Investments in Healthcare Infrastructure in Emerging Markets Expands Market for Inhalation Anesthetics
- Increasing Research on the Long-Term Effects of Anesthetics Creates Opportunities for Safer Formulations
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Inhalation Anesthetics Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
- TABLE 2: World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 3: World Historic Review for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 4: World 13-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
- TABLE 5: World Recent Past, Current & Future Analysis for Sevoflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 6: World Historic Review for Sevoflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 7: World 13-Year Perspective for Sevoflurane Drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 8: World Recent Past, Current & Future Analysis for Desflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 9: World Historic Review for Desflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 10: World 13-Year Perspective for Desflurane Drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 11: World Recent Past, Current & Future Analysis for Isoflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 12: World Historic Review for Isoflurane Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 13: World 13-Year Perspective for Isoflurane Drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 14: World Recent Past, Current & Future Analysis for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 15: World Historic Review for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 16: World 13-Year Perspective for Other Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 17: World Recent Past, Current & Future Analysis for Induction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 18: World Historic Review for Induction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 19: World 13-Year Perspective for Induction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 20: World Recent Past, Current & Future Analysis for Maintenance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 21: World Historic Review for Maintenance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 22: World 13-Year Perspective for Maintenance Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 25: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 28: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 31: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
- III. MARKET ANALYSIS
- UNITED STATES
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 33: USA Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 34: USA 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 35: USA Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 36: USA Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 37: USA 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 38: USA Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 39: USA Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 40: USA 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- CANADA
- TABLE 41: Canada Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 42: Canada Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 43: Canada 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 44: Canada Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 45: Canada Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 46: Canada 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 47: Canada Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 48: Canada Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 49: Canada 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- JAPAN
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
- TABLE 50: Japan Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 51: Japan Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 52: Japan 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 53: Japan Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 54: Japan Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 55: Japan 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 56: Japan Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 57: Japan Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 58: Japan 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- CHINA
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 60: China Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 61: China 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 62: China Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 63: China Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 64: China 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 65: China Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 66: China Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 67: China 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- EUROPE
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 69: Europe Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 70: Europe 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 71: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
- TABLE 72: Europe Historic Review for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 73: Europe 13-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
- TABLE 74: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 75: Europe Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 76: Europe 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 77: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 78: Europe Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 79: Europe 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- FRANCE
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
- TABLE 80: France Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 81: France Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 82: France 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 83: France Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 84: France Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 85: France 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 86: France Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 87: France Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 88: France 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- GERMANY
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
- TABLE 89: Germany Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 90: Germany Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 91: Germany 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 92: Germany Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 93: Germany Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 94: Germany 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 95: Germany Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 96: Germany Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 97: Germany 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- ITALY
- TABLE 98: Italy Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 99: Italy Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 100: Italy 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 101: Italy Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 102: Italy Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 103: Italy 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 104: Italy Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 105: Italy Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 106: Italy 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- UNITED KINGDOM
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
- TABLE 107: UK Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 108: UK Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 109: UK 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 110: UK Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 111: UK Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 112: UK 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 113: UK Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 114: UK Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 115: UK 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- REST OF EUROPE
- TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 117: Rest of Europe Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 118: Rest of Europe 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 120: Rest of Europe Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 121: Rest of Europe 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 123: Rest of Europe Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 124: Rest of Europe 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- ASIA-PACIFIC
- Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
- TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 126: Asia-Pacific Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 127: Asia-Pacific 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 129: Asia-Pacific Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 130: Asia-Pacific 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 132: Asia-Pacific Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 133: Asia-Pacific 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- REST OF WORLD
- TABLE 134: Rest of World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Induction Application and Maintenance Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 135: Rest of World Historic Review for Inhalation Anesthetics by Application - Induction Application and Maintenance Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 136: Rest of World 13-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Induction Application and Maintenance Application for the Years 2020, 2026 & 2032
- TABLE 137: Rest of World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 138: Rest of World Historic Review for Inhalation Anesthetics by Drug - Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 139: Rest of World 13-Year Perspective for Inhalation Anesthetics by Drug - Percentage Breakdown of Value Sales for Sevoflurane Drug, Desflurane Drug, Isoflurane Drug and Other Drugs for the Years 2020, 2026 & 2032
- TABLE 140: Rest of World Recent Past, Current & Future Analysis for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
- TABLE 141: Rest of World Historic Review for Inhalation Anesthetics by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
- TABLE 142: Rest of World 13-Year Perspective for Inhalation Anesthetics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
- IV. COMPETITION
Pricing
Currency Rates



